Department of Applied Oral Sciences, Dalhousie University, 5981 University Ave, Halifax, NS B3H 4R2, Canada.
J Mater Sci Mater Med. 2011 Apr;22(4):945-59. doi: 10.1007/s10856-011-4263-1. Epub 2011 Mar 3.
The objective of this work was to examine the main (individual), combined (interaction) and second-order (quadratic) effects of: (i) poly(D,L-lactide-co-glycolide) (PLGA), (ii) F127, and (iii) a zinc-silicate based bioactive glass, on the cytotoxicity and ultimate tensile strength of an experimental nerve guidance conduit (NGC). The experimental plan was carried out according to a Box-Behnken design matrix. The effects of each compositional factor were quantified using response surface methodology (RSM) techniques. Linear and quadratic polynomial equations were developed to examine cytotoxicity (after incubation at 3, 7 and 28 days) and initial ultimate tensile strength (UTS(0)). Multiple regression analyses showed that the developed models yielded a good prediction for each response examined. It was observed that the beneficial effects of PLGA and bioactive glass on controlling cytotoxicity appeared greater than that of F127. Furthermore, the experimental conduits (with the exception of CNGC-I and CNGC-K) generally showed superior cytocompatibility when compared with the comparable literature for the clinically used nerve guidance conduit Neurolac(®). In this investigation, optimal compositions for cell viability were obtained for the following composition: PLGA = 18.89 wt%/F127 = 0.52 wt%/glass = 12.71 wt%. The optimization of composition with respect to ultimate tensile strength was also established (desired UTS(0) being based on the properties of the control device Neurolac(®) whose UTS is c.20 MPa). The desired UTS(0) of ≤ 20 MPa was found for the composition: PLGA = 18.63 wt%/F127 = 0.77 wt%/glass = 5.54 wt%. A UTS(0) ≤ 30 MPa was recorded for the composition: PLGA = 18.34 wt%/F127 = 0.62 wt%/glass = 9.83 wt%, such tensile strengths are comparable to, reported values for Neurolac(®). Examination of the composition-property relationships with respect to combining cell viability and UTS(0) indicated preferred compositions in the range 17.97-19.90 wt% PLGA, 0.16-1.13 wt% F127 and between 5.54 and ≤ 20 wt% glass. This research demonstrates the value of a design of experiments approach for the design of novel nerve guidance conduits, and shows that the materials examined may have potential for the repair of peripheral nerve discontinuities.
本工作的目的是研究以下主要(个体)、组合(相互作用)和二阶(二次)效应:(i)聚(D,L-丙交酯-共-乙交酯)(PLGA),(ii)F127,和(iii)基于锌-硅酸盐的生物活性玻璃,对实验性神经引导管(NGC)的细胞毒性和最终拉伸强度的影响。实验计划根据 Box-Behnken 设计矩阵进行。使用响应面法(RSM)技术定量评估每个组成因素的影响。开发了线性和二次多项式方程来检查细胞毒性(孵育 3、7 和 28 天后)和初始最终拉伸强度(UTS(0))。多元回归分析表明,所开发的模型对每个检查的响应均能很好地预测。观察到 PLGA 和生物活性玻璃对控制细胞毒性的有益影响似乎大于 F127。此外,与临床使用的神经引导管 Neurolac(®)的可比文献相比,实验导管(CNGC-I 和 CNGC-K 除外)通常表现出更好的细胞相容性。在本研究中,对于以下组成获得了细胞活力的最佳组成:PLGA=18.89wt%/F127=0.52wt%/玻璃=12.71wt%。还建立了关于最终拉伸强度的组成优化(基于对照装置 Neurolac(®)的性能,其 UTS 约为 20MPa)。发现对于组成:PLGA=18.63wt%/F127=0.77wt%/玻璃=5.54wt%,期望的 UTS(0)≤20MPa。对于组成:PLGA=18.34wt%/F127=0.62wt%/玻璃=9.83wt%,记录到 UTS(0)≤30MPa,这种拉伸强度与 Neurolac(®)报道的值相当。关于将细胞活力和 UTS(0)结合起来的组成-性能关系的检查表明,在 17.97-19.90wt%PLGA、0.16-1.13wt%F127 和 5.54-20wt%玻璃的范围内具有潜在的优选组成。这项研究证明了实验设计方法在设计新型神经引导管方面的价值,并表明所检查的材料可能有潜力用于修复周围神经的不连续性。